RSV 2024
The provision of immunisation products indicated for the prevention or protection from Respiratory Syncytial Virus (RSV) lower respiratory tract disease The contracting authority estimates their requirement for deliveries between 1 July 2024 to 30 June 2026 ('Initial Term') of the contract to be up to 1.6 million doses for Lot 1, up to 1.69 million doses for Lot 2, up to 1.45 million doses for Lot 3 or up to 4 million doses for Lot 4, with the option to extend for up to an additional 24 months.
Buyer
UK Health Security Agency
Value
Not provided
Published
27 Nov 2023
Closes
27 Nov 2023
Procurement details
Source
Contracts Finder
Region
Tower Hamlets
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33651600
Vaccines
Lots
Lot default RSV 2024
Value not provided
The provision of immunisation products indicated for the prevention or protection from Respiratory Syncytial Virus (RSV) lower respiratory tract disease The contracting authority estimates their requirement for deliveries between 1 July 2024 to 30 June 2026 ('Initial Term') of the contract to be up to 1.6 million doses for Lot 1, up to 1.69 million doses for...
Delivery: United Kingdom
Documents
Unlock document linkFuture opportunity notice on Contracts Finder
27 Nov 2023
Future opportunity notice on Contracts Finder
Planned procurement notice · Web page
Published PIN
Not provided
Published PIN
Contains public sector information licensed under the Open Government Licence v3.0.